DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
19.22
-0.28 (-1.44%)
Feb 13, 2026, 3:00 PM CST

SHA:603233 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
26,19825,86123,93120,78016,75914,262
Other Revenue
635.56635.56599.94467.67-320.64
26,83426,49724,53121,24816,75914,583
Revenue Growth (YoY)
1.11%8.01%15.45%26.78%14.92%30.89%
Cost of Revenue
17,61417,42215,79513,22610,3858,993
Gross Profit
9,2209,0748,7368,0226,3745,590
Selling, General & Admin
7,2407,4246,8086,2705,1874,173
Research & Development
49.4751.6880.9374.3844.614.7
Other Operating Expenses
68.3835.4735.3264.5729.9444.27
Operating Expenses
7,3707,5276,9406,4325,2734,227
Operating Income
1,8501,5471,7961,5901,1011,363
Interest Expense
-222.43-248.83-239.26-231.97-212.04-11.5
Interest & Investment Income
81.1382.2391.7568.8977.767.69
Other Non Operating Income (Expenses)
-44.45-46.32-49.85-48.52-29.15-29.91
EBT Excluding Unusual Items
1,6651,3351,5991,379937.761,389
Impairment of Goodwill
-38.6-38.6-6.21---
Gain (Loss) on Sale of Investments
20.5910.614.38-18.7134.572.75
Gain (Loss) on Sale of Assets
20.6719.213.4318.735.63-2.53
Asset Writedown
1.44-----
Other Unusual Items
13.8913.8927.0536.3665.9457.33
Pretax Income
1,6831,3401,6281,4151,0441,446
Income Tax Expense
457.04359.73397.12335.62239.52363.39
Earnings From Continuing Operations
1,226979.941,2311,079804.391,083
Minority Interest in Earnings
-87.87-65.19-64.16-43.55-13.16-20.84
Net Income
1,138914.751,1661,036791.231,062
Net Income to Common
1,138914.751,1661,036791.231,062
Net Income Growth
33.80%-21.58%12.63%30.90%-25.51%51.17%
Shares Outstanding (Basic)
1,1251,1291,1331,1381,1301,133
Shares Outstanding (Diluted)
1,1251,1291,1331,1381,1301,133
Shares Change (YoY)
-0.96%-0.28%-0.50%0.69%-0.24%2.65%
EPS (Basic)
1.010.811.030.910.700.94
EPS (Diluted)
1.010.811.030.910.700.94
EPS Growth
35.09%-21.36%13.19%30.00%-25.33%47.27%
Free Cash Flow
3,9221,6301,3772,722260.051,162
Free Cash Flow Per Share
3.491.441.222.390.231.02
Dividend Per Share
0.6500.6200.3100.5000.3470.463
Dividend Growth
4.84%100.00%-38.00%43.97%-24.99%60.04%
Gross Margin
34.36%34.25%35.61%37.76%38.03%38.33%
Operating Margin
6.89%5.84%7.32%7.48%6.57%9.34%
Profit Margin
4.24%3.45%4.75%4.87%4.72%7.28%
Free Cash Flow Margin
14.62%6.15%5.61%12.81%1.55%7.96%
EBITDA
3,5363,1313,2441,8081,3061,533
EBITDA Margin
13.18%11.82%13.22%8.51%7.79%10.51%
D&A For EBITDA
1,6851,5841,448218.06204.62170.77
EBIT
1,8501,5471,7961,5901,1011,363
EBIT Margin
6.89%5.84%7.32%7.48%6.57%9.34%
Effective Tax Rate
27.16%26.85%24.40%23.72%22.94%25.12%
Revenue as Reported
26,83426,49724,53121,24816,75914,583
Advertising Expenses
-25.4930.8126.27--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.